BACKGROUND: The assumption that the assessment of forced expiratory flow between 25% and 75% of vital capacity (FEF(25-75)) does not provide additional information in asthmatic children with normal FEV(1) percent predicted has not been adequately tested. OBJECTIVE: We sought to determine whether the measurement of FEF(25-75) percent predicted offers advantages over FEV(1) percent predicted and FEV(1)/forced vital capacity (FVC) percent predicted for the evaluation of childhood asthma. METHODS: This is a secondary analysis of data from the Pediatric Asthma Controller Trial and the Characterizing the Response to a Leukotriene Receptor Antagonist and Inhaled Corticosteroid trials. Pearson correlation coefficients, Pearson partial correlation coefficients, canonical correlations, and receiver operating characteristic (ROC) curves were constructed. RESULTS: Among 437 children with normal FEV(1) percent predicted, FEF(25-75) percent predicted, and FEV(1)/FVC percent predicted were (1) positively correlated with log(2) methacholine PC(20), (2) positively correlated with morning and evening peak expiratory flow percent predicted, and (3) negatively correlated with log(10) fraction of exhaled nitric oxide and bronchodilator responsiveness. Pearson partial correlations and canonical correlations indicated that FEF(25-75) percent predicted was better correlated with bronchodilator responsiveness and log(2) methacholine PC(20) than were FEV(1) percent predicted or FEV(1)/FVC percent predicted. In the ROC curve analysis, FEF(25-75) at 65% of predicted value had a 90% sensitivity and a 67% specificity for detecting a 20% increase in FEV(1) after albuterol inhalation. CONCLUSION: FEF(25-75) percent predicted was well correlated with bronchodilator responsiveness in asthmatic children with normal FEV(1). FEF(25-75) percent predicted should be evaluated in clinical studies of asthma in children and might be of use in predicting the presence of clinically relevant reversible airflow obstruction.
BACKGROUND: The assumption that the assessment of forced expiratory flow between 25% and 75% of vital capacity (FEF(25-75)) does not provide additional information in asthmatic children with normal FEV(1) percent predicted has not been adequately tested. OBJECTIVE: We sought to determine whether the measurement of FEF(25-75) percent predicted offers advantages over FEV(1) percent predicted and FEV(1)/forced vital capacity (FVC) percent predicted for the evaluation of childhood asthma. METHODS: This is a secondary analysis of data from the Pediatric Asthma Controller Trial and the Characterizing the Response to a Leukotriene Receptor Antagonist and Inhaled Corticosteroid trials. Pearson correlation coefficients, Pearson partial correlation coefficients, canonical correlations, and receiver operating characteristic (ROC) curves were constructed. RESULTS: Among 437 children with normal FEV(1) percent predicted, FEF(25-75) percent predicted, and FEV(1)/FVC percent predicted were (1) positively correlated with log(2) methacholine PC(20), (2) positively correlated with morning and evening peak expiratory flow percent predicted, and (3) negatively correlated with log(10) fraction of exhaled nitric oxide and bronchodilator responsiveness. Pearson partial correlations and canonical correlations indicated that FEF(25-75) percent predicted was better correlated with bronchodilator responsiveness and log(2) methacholine PC(20) than were FEV(1) percent predicted or FEV(1)/FVC percent predicted. In the ROC curve analysis, FEF(25-75) at 65% of predicted value had a 90% sensitivity and a 67% specificity for detecting a 20% increase in FEV(1) after albuterol inhalation. CONCLUSION: FEF(25-75) percent predicted was well correlated with bronchodilator responsiveness in asthmatic children with normal FEV(1). FEF(25-75) percent predicted should be evaluated in clinical studies of asthma in children and might be of use in predicting the presence of clinically relevant reversible airflow obstruction.
Authors: Kelan G Tantisira; Anne L Fuhlbrigge; James Tonascia; Mark Van Natta; Robert S Zeiger; Robert C Strunk; Stanley J Szefler; Scott T Weiss Journal: J Allergy Clin Immunol Date: 2006-04-27 Impact factor: 10.793
Authors: R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger Journal: Eur Respir J Date: 2005-11 Impact factor: 16.671
Authors: Wayne J Morgan; Debra A Stern; Duane L Sherrill; Stefano Guerra; Catharine J Holberg; Theresa W Guilbert; Lynn M Taussig; Anne L Wright; Fernando D Martinez Journal: Am J Respir Crit Care Med Date: 2005-08-18 Impact factor: 21.405
Authors: Christine A Sorkness; Robert F Lemanske; David T Mauger; Susan J Boehmer; Vernon M Chinchilli; Fernando D Martinez; Robert C Strunk; Stanley J Szefler; Robert S Zeiger; Leonard B Bacharier; Gordon R Bloomberg; Ronina A Covar; Theresa W Guilbert; Gregory Heldt; Gary Larsen; Michael H Mellon; Wayne J Morgan; Mark H Moss; Joseph D Spahn; Lynn M Taussig Journal: J Allergy Clin Immunol Date: 2006-11-30 Impact factor: 10.793
Authors: Eduard E de Lange; Talissa A Altes; James T Patrie; John D Gaare; Jeffrey J Knake; John P Mugler; Thomas A Platts-Mills Journal: Chest Date: 2006-10 Impact factor: 9.410
Authors: Sunita Sharma; Augusto A Litonjua; Kelan G Tantisira; Anne L Fuhlbrigge; Stanley J Szefler; Robert C Strunk; Robert S Zeiger; Amy J Murphy; Scott T Weiss Journal: J Allergy Clin Immunol Date: 2008-10-10 Impact factor: 10.793
Authors: Kelechi Isiugo; Roman Jandarov; Jennie Cox; Patrick Ryan; Nicholas Newman; Sergey A Grinshpun; Reshmi Indugula; Steven Vesper; Tiina Reponen Journal: Sci Total Environ Date: 2019-01-24 Impact factor: 7.963
Authors: Kelly J Brunst; Patrick H Ryan; James E Lockey; David I Bernstein; Roy T McKay; Gurjit K Khurana Hershey; Manuel Villareal; Jocelyn M Biagini Myers; Linda Levin; Jeff Burkle; Sherry Evans; Grace K Lemasters Journal: Pediatr Allergy Immunol Date: 2012-03-22 Impact factor: 6.377
Authors: Terrie Vasilopoulos; Michael D Grant; Carol E Franz; Matthew S Panizzon; Hong Xian; Rosemary Toomey; Michael J Lyons; William S Kremen; Kristen C Jacobson Journal: Behav Genet Date: 2013-01-09 Impact factor: 2.805
Authors: Terrie Vasilopoulos; William S Kremen; Michael D Grant; Matthew S Panizzon; Hong Xian; Rosemary Toomey; Michael J Lyons; Kristen C Jacobson; Carol E Franz Journal: J Epidemiol Community Health Date: 2014-10-01 Impact factor: 3.710
Authors: Devika R Rao; Jonathan M Gaffin; Sachin N Baxi; William J Sheehan; Elaine B Hoffman; Wanda Phipatanakul Journal: J Asthma Date: 2012-06-28 Impact factor: 2.515